Recent Finacing
Recent Raise
AlveoGene develops an inhaled lentiviral gene therapy platform for rare respiratory diseases, using a proprietary lentiviral delivery system from the UK Respiratory Gene Therapy Consortium, initially targeting AATD.
Focus Areas
Recent Investors
Funding round
Investors